IoT Infusion Pumps Market Outlook: Rise in Adoption of Precision Drug Delivery to Drive Market Growth to US$ 32.63 Billion by 2033

As per the latest market research by Business Market Insights (BMI), the research report "IoT Infusion Pumps Market Outlook Size and Forecast (2022–2033)" forecasts how the market is set to surge 287.5% by 2033 as growing adoption of precision drug delivery reshapes the IoT infusion pumps ecosystem. The report highlights technological advancements such as integration with electronic health records, revolutionizing the global landscape of IoT infusion pumps.

The report forecasts the market to expand from US$ 8.42 billion in 2024 to US$ 32.63 billion by 2033, registering a robust CAGR of 16.24% over the 2025–2033 period.

Technological advancements, particularly the integration of IoT infusion pumps with electronic health records (EHRs), are revolutionizing the global healthcare landscape by enabling seamless, data‑driven treatment delivery. Traditionally, infusion therapy relied on manual documentation and isolated monitoring systems, which often led to inefficiencies and potential errors. With EHR integration, IoT infusion pumps now transmit real‑time dosage, flow rate, and patient response data directly into centralized digital records, ensuring clinicians have a comprehensive view of therapy progress. This connectivity enhances clinical decision‑making, supports precision drug delivery, and reduces the risk of adverse events by allowing immediate adjustments based on patient‑specific needs. Hospitals benefit from improved workflow efficiency, as automated data entry minimizes administrative burden and strengthens compliance with regulatory standards. Moreover, integration with EHRs facilitates interoperability across healthcare networks, enabling remote monitoring and telemedicine applications that extend infusion therapy beyond hospital walls into homecare settings. For payers and regulators, this advancement provides transparent, auditable data streams that improve accountability and cost management. As healthcare systems worldwide prioritize digital transformation, the convergence of IoT infusion pumps and EHR platforms is redefining infusion therapy, positioning connected devices as essential tools for personalized medicine, operational efficiency, and global patient safety. ​‍​‌‍​‍‌​

Overview of report findings

Market Growth

The IoT Infusion Pumps Market is projected to grow from US$ 8.42 billion in 2024 to US$ 32.63 billion by 2033, registering a compound annual growth rate (CAGR) of 16.24% between 2025 and 2033.

The rising adoption of precision drug delivery and increasing home infusion therapy are key factors propelling market growth. Advancements such as integration with electronic health records are transforming the landscape of IoT infusion pumps.

Rising Adoption of Precision Drug Delivery    

The rising adoption of precision drug delivery is emerging as a powerful driver for the IoT infusion pumps market, transforming how therapies are administered and monitored across healthcare systems. Traditional infusion methods often relied on standardized dosing protocols, which could not fully account for individual patient variability. IoT-enabled infusion pumps, however, are designed to deliver medications with exact timing, dosage, and flow rates tailored to each patient’s unique clinical profile. This precision is particularly critical in areas such as oncology, diabetes management, and pain control, where even minor deviations in drug administration can significantly impact outcomes. By integrating sensors, connectivity, and real-time analytics, IoT infusion pumps enable clinicians to adjust therapies dynamically, ensuring optimal efficacy while minimizing adverse effects. The growing emphasis on personalized medicine further accelerates this trend, as healthcare providers seek solutions that align with genomic insights and patient-specific treatment plans. Moreover, precision drug delivery reduces wastage, improves resource utilization, and enhances patient safety, making it attractive for both hospitals and payers. As regulatory bodies increasingly endorse technologies that support individualized care, the adoption of IoT infusion pumps for precision drug delivery is expected to expand rapidly, positioning it as a cornerstone of modern therapeutic practice.

Increasing Home Infusion Therapy

The increasing adoption of home infusion therapy is emerging as a significant driver for the IoT infusion pumps market, reshaping how patients receive treatment and how healthcare systems manage chronic conditions. Traditionally, infusion therapies such as chemotherapy, antibiotic administration, and pain management required prolonged hospital stays, which placed a heavy burden on both patients and healthcare infrastructure. However, the growing preference for home‑based care is shifting demand toward portable, connected infusion pumps that allow patients to receive treatment in the comfort of their own homes. IoT‑enabled devices provide real‑time monitoring, dosage accuracy, and remote connectivity, enabling clinicians to track patient progress and intervene promptly if complications arise. This not only enhances patient convenience and quality of life but also reduces hospital readmissions and overall treatment costs. The trend is particularly strong among aging populations and individuals with chronic diseases, who benefit from continuous therapy without frequent hospital visits. Insurers and governments are increasingly supportive of home infusion programs, recognizing their cost‑effectiveness and ability to expand access to care. As healthcare delivery models evolve toward decentralization, the rising demand for home infusion therapy is accelerating the adoption of IoT infusion pumps, positioning them as essential tools in modern patient‑centric care.

Geographic Insights

North America is the largest region in the IoT infusion pumps market, supported by advanced healthcare infrastructure, high adoption of connected medical technologies, and strong reimbursement frameworks that encourage hospitals and clinics to invest in smart infusion systems. The United States leads with widespread integration of IoT pumps into electronic health records and clinical workflows, while Canada complements growth through telemedicine initiatives that extend infusion monitoring to rural populations. Europe ranks as the second largest region, driven by mature public healthcare systems, aging demographics, and strict EU MDR regulations that ensure device safety and interoperability. Western European countries such as Germany, France, and the UK are at the forefront of adoption, embedding IoT infusion pumps into national health strategies, while Eastern Europe is gradually scaling through government‑backed e‑health programs. Asia Pacific, meanwhile, is the fastest‑growing region, propelled by its vast population base, rising incidence of chronic diseases, and rapid digital health transformation. China and India dominate growth with expanding middle classes and government investment in healthcare modernization, while Japan, South Korea, and Australia emphasize advanced monitoring and remote care solutions. Together, these dynamics highlight North America’s scale, Europe’s regulatory maturity, and Asia Pacific’s rapid expansion in shaping the global IoT infusion pumps market.

Market Segmentation

• Based on Product, the market is segmented into IoT insulin pumps, syringe infusion pumps, volumetric infusion pumps, ambulatory infusion pumps, patient-controlled analgesia pumps, and others. The IoT insulin pumps segment dominated the market in 2024.
• Based on Technology, the market is segmented into Wi-Fi, Bluetooth, cellular, and others. The Wi-Fi segment dominated the market in 2024.
• Based on Application, the market is segmented into chemotherapy delivery, diabetes management, pain management, nutritional infusion, and others. The chemotherapy delivery segment dominated the market in 2024.

• Based on End User, the market is segmented into hospitals & clinics, home care settings, and others. The hospitals & clinics dominated the market in 2024.

Competitive Strategy & Development

Key Players: The IoT Infusion Pumps Market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Medtronic Plc
2. Baxter International Inc
3. Moog, Inc.
4. ICU Medical Inc.
5. Abbott Laboratories
6. Boston Scientific Corporation

Trending Topics: Smart digitization of infusion systems, AI‑driven personalization of drug delivery, Integration with electronic health records (EHRs), Predictive maintenance using machine learning, Decentralization of care through home‑based therapies, Enhanced patient safety features, Cloud‑based connectivity and interoperability, Cybersecurity for connected medical devices, Growing prevalence of chronic diseases

Global Headlines

• " Baxter International Raises Profit Forecast as Demand for Infusion Pumps Surges - In May 2024, Baxter International updated its 2024 profit outlook upward, citing stronger-than-expected demand for its medical-device segment — particularly its infusion pumps and dialysis products. The surge reflects rising demand for infusion therapy in hospitals and home-care settings, partly driven by a backlog of delayed procedures and growing chronic care needs."
• " ICU Medical Warned by FDA Over Unreviewed Changes to Infusion Pumps - In April 2025, The U.S. Food and Drug Administration (FDA) issued a warning letter to ICU Medical, alleging the company failed to submit required pre-market notifications for modifications to its Medfusion 4000 syringe pump and CADD Solis VIP ambulatory infusion pump. The changes could affect safety or performance — highlighting regulatory scrutiny around IoT-enabled infusion devices."

Conclusion

The IoT infusion pumps market is positioned for strong expansion as healthcare systems increasingly prioritize precision, safety, and connectivity in medication delivery. As reflected in the snapshot, key growth drivers—including rising demand for accurate drug administration, heightened focus on reducing medication errors, and the rapid adoption of home infusion therapy—are pushing providers toward smarter, digitally enabled infusion solutions. These connected pumps enable real-time monitoring, automated dosage adjustments, and continuous data sharing, significantly improving patient safety while reducing clinical workload. Looking ahead, seamless integration with electronic health records and pharmacy systems represents a major future trend that will further elevate the value of IoT-enabled infusion devices. Such interoperability will allow for streamlined workflows, automated documentation, and enhanced medication oversight, ultimately supporting more coordinated and efficient care delivery. At the same time, ongoing challenges such as security, privacy concerns, and the absence of universal standards must be addressed to ensure reliable system performance and protect sensitive medical data. Despite these hurdles, opportunities remain substantial, particularly in the development of specialized and wearable infusion systems that offer greater mobility and personalized therapy options. As innovation in IoT, analytics, and miniaturized hardware accelerates, the market is expected to evolve rapidly, reinforcing its critical role in modern, connected healthcare.